Plain-English translation of NCT06464159 on ClinicalTrials.gov ↗ ·
Researchers are studying a new treatment approach for preeclampsia, a serious pregnancy condition where blood pressure becomes dangerously high. This trial is collecting blood samples from pregnant women — some with preeclampsia and some with healthy pregnancies — to understand what protein imbalances occur in the disease and who might benefit most from a new type of blood-filtering treatment.
Preeclampsia affects many pregnant women and can be life-threatening for both mother and baby. Doctors know that this condition involves an imbalance of certain proteins in the blood, but different women have different protein patterns. This trial aims to figure out which patients would be the best candidates for a new blood-cleaning therapy designed to restore the protein balance.
You likely qualify if…
You likely don't qualify if…
You would visit a hospital clinic once during your pregnancy to have a blood sample taken. The researchers will collect your blood at a specific stage of pregnancy (they're enrolling women at five different time points throughout pregnancy). The blood will be analyzed to measure certain proteins, and your information will be stored in a research database to help doctors understand which patients might benefit from the new blood-filtering treatment in the future. There are no medications to take or ongoing procedures — just a single blood draw visit.
AI-generated summary from trial data · Jul 19, 2026 · Not medical advice
France